BVS

Bioventus Inc.
7 filings tracked
healthcaremedical devicesSMALL ($300M-2B)

Signal Magnitude Chart

BULLISH | 70% | 5/6/2026 | earnings beatBULLISH | 60% | 5/6/2026 | margin expansionBULLISH | 80% | 5/6/2026 | debt restructureBEARISH | 50% | 5/6/2026 | regulatory actionBULLISH | 70% | 5/6/2026 | earnings beatBULLISH | 60% | 5/6/2026 | margin expansionBULLISH | 80% | 5/6/2026 | debt restructureBEARISH | 50% | 5/6/2026 | regulatory actionBULLISH | 70% | 5/6/2026 | earnings beatBULLISH | 60% | 5/6/2026 | margin expansionBULLISH | 80% | 5/6/2026 | debt restructureBEARISH | 50% | 5/6/2026 | regulatory actionBULLISH | 70% | 5/6/2026 | earnings beatBULLISH | 60% | 5/6/2026 | margin expansionBULLISH | 80% | 5/6/2026 | debt restructureBEARISH | 50% | 5/6/2026 | regulatory actionBULLISH | 70% | 5/6/2026 | earnings beatBULLISH | 60% | 5/6/2026 | margin expansionBULLISH | 80% | 5/6/2026 | debt restructureBEARISH | 50% | 5/6/2026 | regulatory actionBULLISH | 70% | 5/6/2026 | earnings beatBULLISH | 60% | 5/6/2026 | margin expansionBULLISH | 80% | 5/6/2026 | debt restructureBEARISH | 50% | 5/6/2026 | regulatory actionBULLISH | 70% | 5/6/2026 | earnings beatBULLISH | 60% | 5/6/2026 | margin expansionBULLISH | 80% | 5/6/2026 | debt restructureBEARISH | 50% | 5/6/2026 | regulatory actionMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bullishMay 6

Swung from a net loss to a net income of $3.9 million year-over-year.

earnings beat
70%
bullishMay 6

Gross margins increased 170 basis points to 68.7%.

margin expansion
60%
bullishMay 6

Executed $22M discretionary debt prepayment and reduced interest expense by 42.4%.

debt restructure
80%
bearishMay 6

Ongoing derivative shareholder litigation alleging fiduciary breaches and disclosure failures.

regulatory action
50%
bullishMay 6

Swung from a net loss to a net income of $3.9 million year-over-year.

earnings beat
70%
bullishMay 6

Gross margins increased 170 basis points to 68.7%.

margin expansion
60%
bullishMay 6

Executed $22M discretionary debt prepayment and reduced interest expense by 42.4%.

debt restructure
80%
bearishMay 6

Ongoing derivative shareholder litigation alleging fiduciary breaches and disclosure failures.

regulatory action
50%
bullishMay 6

Swung from a net loss to a net income of $3.9 million year-over-year.

earnings beat
70%
bullishMay 6

Gross margins increased 170 basis points to 68.7%.

margin expansion
60%
bullishMay 6

Executed $22M discretionary debt prepayment and reduced interest expense by 42.4%.

debt restructure
80%
bearishMay 6

Ongoing derivative shareholder litigation alleging fiduciary breaches and disclosure failures.

regulatory action
50%
bullishMay 6

Swung from a net loss to a net income of $3.9 million year-over-year.

earnings beat
70%
bullishMay 6

Gross margins increased 170 basis points to 68.7%.

margin expansion
60%
bullishMay 6

Executed $22M discretionary debt prepayment and reduced interest expense by 42.4%.

debt restructure
80%
bearishMay 6

Ongoing derivative shareholder litigation alleging fiduciary breaches and disclosure failures.

regulatory action
50%
bullishMay 6

Swung from a net loss to a net income of $3.9 million year-over-year.

earnings beat
70%
bullishMay 6

Gross margins increased 170 basis points to 68.7%.

margin expansion
60%
bullishMay 6

Executed $22M discretionary debt prepayment and reduced interest expense by 42.4%.

debt restructure
80%
bearishMay 6

Ongoing derivative shareholder litigation alleging fiduciary breaches and disclosure failures.

regulatory action
50%
bullishMay 6

Swung from a net loss to a net income of $3.9 million year-over-year.

earnings beat
70%
bullishMay 6

Gross margins increased 170 basis points to 68.7%.

margin expansion
60%
bullishMay 6

Executed $22M discretionary debt prepayment and reduced interest expense by 42.4%.

debt restructure
80%
bearishMay 6

Ongoing derivative shareholder litigation alleging fiduciary breaches and disclosure failures.

regulatory action
50%
bullishMay 6

Swung from a net loss to a net income of $3.9 million year-over-year.

earnings beat
70%
bullishMay 6

Gross margins increased 170 basis points to 68.7%.

margin expansion
60%
bullishMay 6

Executed $22M discretionary debt prepayment and reduced interest expense by 42.4%.

debt restructure
80%
bearishMay 6

Ongoing derivative shareholder litigation alleging fiduciary breaches and disclosure failures.

regulatory action
50%